tiprankstipranks
Teva Pharmaceutical Industries Limited (IL:TEVA)
TASE:TEVA
Israel Market
Want to see IL:TEVA full AI Analyst Report?

Teva (TEVA) Stock Statistics & Valuation Metrics

54 Followers

Total Valuation

Teva has a market cap or net worth of ₪121.47B. The enterprise value is 154.00K.
Market Cap₪121.47B
Enterprise Value154.00K

Share Statistics

Teva has 1,164,638,700 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,164,638,700
Owned by Insiders
Owned by Institutions<0.01%

Financial Efficiency

Teva’s return on equity (ROE) is 0.19 and return on invested capital (ROIC) is 14.69%.
Return on Equity (ROE)0.19
Return on Assets (ROA)0.04
Return on Invested Capital (ROIC)14.69%
Return on Capital Employed (ROCE)0.16
Revenue Per Employee560.23K
Profits Per Employee45.80K
Employee Count33,346
Asset Turnover0.46
Inventory Turnover2.85

Valuation Ratios

The current PE Ratio of Teva is 53.5. Teva’s PEG ratio is -0.14.
PE Ratio53.5
PS Ratio1.94
PB Ratio4.58
Price to Fair Value4.58
Price to FCF14.18
Price to Operating Cash Flow13.60
PEG Ratio-0.14

Income Statement

In the last 12 months, Teva had revenue of 18.68B and earned 1.53B in profits. Earnings per share was 1.23.
Revenue18.68B
Gross Profit9.63B
Operating Income4.28B
Pretax Income1.34B
Net Income1.53B
EBITDA3.42B
Earnings Per Share (EPS)1.23

Cash Flow

In the last 12 months, operating cash flow was 2.93B and capital expenditures -551.37M, giving a free cash flow of 2.38B billion.
Operating Cash Flow2.93B
Free Cash Flow2.38B
Free Cash Flow per Share2.05

Dividends & Yields

Teva pays an annual dividend of 8.5, resulting in a dividend yield of ―
Dividend Per Share8.5
Dividend Yield
Payout Ratio
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta0.52
52-Week Price Change89.01%
50-Day Moving Average9.92K
200-Day Moving Average9.49K
Relative Strength Index (RSI)56.04
Average Volume (3m)1.92M

Important Dates

Teva upcoming earnings date is Nov 11, 2026, Before Open (Confirmed).
Last Earnings DateJul 29, 2026
Next Earnings DateNov 11, 2026
Ex-Dividend Date

Financial Position

Teva as a current ratio of 1.04, with Debt / Equity ratio of 216.19%
Current Ratio1.04
Quick Ratio0.80
Debt to Market Cap0.46
Net Debt to EBITDA4.04
Interest Coverage Ratio4.23

Taxes

In the past 12 months, Teva has paid -194.84M in taxes.
Income Tax-194.84M
Effective Tax Rate-0.15

Enterprise Valuation

Teva EV to EBITDA ratio is 14.64, with an EV/FCF ratio of 19.59.
EV to Sales2.68
EV to EBITDA14.64
EV to Free Cash Flow19.59
EV to Operating Cash Flow16.16

Balance Sheet

Teva has ₪3.63B in cash and marketable securities with ₪16.76B in debt, giving a net cash position of -₪13.13B billion.
Cash & Marketable Securities₪3.63B
Total Debt₪16.76B
Net Cash-₪13.13B
Net Cash Per Share-₪11.27
Tangible Book Value Per Share-₪10.37

Margins

Gross margin is 52.41%, with operating margin of 22.90%, and net profit margin of 8.18%.
Gross Margin52.41%
Operating Margin22.90%
Pretax Margin7.17%
Net Profit Margin8.18%
EBITDA Margin18.31%
EBIT Margin12.50%

Analyst Forecast

The average price target for Teva is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target
Price Target Upside
Analyst Consensus
Analyst Count0
Revenue Growth Forecast-9.13%
EPS Growth Forecast

Scores

Smart ScoreN/A
AI Score